Crizotinib, KESODX, Crizotinib

Crizotinib is an ALK and ROS1 inhibitor used to treat non-small cell lung cancer. Crizotinib inhibits c-Met/hepatocyte growth factor receptor tyrosine kinase, which is involved in the development of many other histological forms of malignancy.